A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, ...

Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

Reports Q4 revenue $966M, consensus $941.14M. The company reported $923M in Spikevax sales in the fourth quarter of 2024 and $15M in mRESVIA ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

Explore the truth behind false claims that Moderna's CEO confessed to creating a COVID-19 vaccine before the pandemic, and the context of his remarks on vaccine production.

The coronavirus will never disappear, Moderna CEO Stephan Bancel said during a panel earlier this week. “We are going to live with this virus, we think, forever,” he said. Separately ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Moderna (NASDAQ:MRNA) CEO Stéphane Bancel said that the vaccine maker aims to reduce 2025 cash costs by $1 billion with a plan for an additional $500 million in 2026. It expects to end 2025 with ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

In response, Moderna has slashed 2025 guidance twice in the past four months, most recently just eight days after CEO Stephane Bancel wrote in his Moderna 2024 Shareholder Letter that “There are ...